Atlas Trials

Pilot Study of Biomarkers of Response to Immune Checkpoint Blockade in Metastatic Melanoma

Clinical trial NCT03356470 · COMPLETED

Trial details

NCT number
NCT03356470
Sponsor
University of Wisconsin, Madison
Status
COMPLETED
Study type
OBSERVATIONAL
Melanoma
Start date
2017-11-02
Primary completion
2022-06-17
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.